Essential hypertension: Clinical sciences

Last updated: September 26, 2025

Essential hypertension: Clinical sciences

STAGE DE PÉDIATRIE

STAGE DE PÉDIATRIE

Henoch-Schonlein purpura: Clinical sciences
Approach to inborn errors of metabolism (progressive or chronic): Clinical sciences
Meningitis (pediatrics): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Sickle cell disease: Clinical sciences
Sepsis (pediatrics): Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to a cough (pediatrics): Clinical sciences
Bronchiolitis: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Influenza: Clinical sciences
Croup and epiglottitis: Clinical sciences
Congestive heart failure: Clinical sciences
Asthma: Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Infectious gastroenteritis (acute) (pediatrics): Clinical sciences
Infectious gastroenteritis (subacute) (pediatrics): Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to viral exanthems (pediatrics): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to hematuria (pediatrics): Clinical sciences
Nephritic syndromes (pediatrics): Clinical sciences
Approach to leukocoria (pediatrics): Clinical sciences
Hepatitis B: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to common musculoskeletal injuries (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Human immunodeficiency virus (HIV) infection: Clinical sciences
Approach to proteinuria (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Conjunctival disorders: Clinical sciences
Eyelid disorders: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Gastroesophageal reflux disease (pediatrics): Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Peptic ulcers, gastritis, and duodenitis (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Respiratory failure (pediatrics): Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Dehydration (pediatrics): Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Burns: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to short stature: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Allergic rhinitis: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Bacterial and viral skin infections: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Viral exanthems of childhood: Pathology review
Seizures: Pathology review
Congenital TORCH infections: Pathology review
Central nervous system infections: Pathology review
Developmental and learning disorders: Pathology review
Breastfeeding
Anatomy clinical correlates: Eye

Decision-Making Tree

Transcript

Watch video only

Essential hypertension is a chronic condition that occurs when an individual’s blood pressure is persistently elevated, without an identifiable cause. It’s a significant contributor to the development of atherosclerotic cardiovascular disease, or ASCVD. Diagnosis also includes assessing for the presence of other ASCVD risk factors; ruling out secondary causes with screening history, physical and labs; and classifying your patient’s blood pressure readings into one of the three groups: Elevated Blood Pressure, formerly known as pre-hypertension, with a systolic blood pressure between 120 and 129 and diastolic blood pressure less than 80 mmHg; Stage 1 hypertension with a systolic blood pressure between 130 and 139 or diastolic blood pressure between 80 to 89 mmHg; or Stage 2 hypertension with a systolic blood pressure greater than or equal to 140 or diastolic blood pressure greater than or equal to 90 mmHg.

Now, if you suspect essential hypertension, perform an ABCDE assessment to determine if the patient is stable or unstable. If unstable, stabilize their airway, breathing, and circulation. Additionally, obtain IV access, provide supplemental oxygen, and put them on continuous vital sign monitoring including blood pressure, heart rate, and pulse oximetry.

Next, proceed with a focused history and physical examination and obtain CMP, troponin, and urinalysis. Also, don't forget to order an ECG and chest X-ray. Together, these will help you identify target organ damage.

Now, your patient might report vision changes, headache, shortness of breath, chest pain, or back pain. Their physical exam may reveal a systolic blood pressure of 180 or a diastolic blood pressure of 120 or greater. Additionally, the exam might reveal altered mental status, respiratory crackles, or decreased peripheral pulses.

As for labs, you may see an elevated creatinine on CMP, an elevated troponin, and proteinuria on the urinalysis. The ECG might show ST segment changes, atrial fibrillation, or left ventricular hypertrophy, while the chest X-ray may reveal a widened mediastinum* or pulmonary edema**.

These findings indicate target organ damage. The combination of severely elevated blood pressure, often with systolic blood pressure over 180 or diastolic blood pressure over 120, and evidence of target organ damage indicates Hypertensive Emergency.

Treatment consists of IV antihypertensive medications, such as certain beta-blockers, like labetalol; calcium channel blockers, like nicardipine; or vasodilators, like hydralazine. Here’s a high yield fact! When there’s severely elevated blood pressure without evidence of target organ damage, that’s Hypertensive Urgency. In these patients, blood pressure can be reduced gradually with oral antihypertensives.

Okay, let’s go back and look at stable patients. If your patient is stable, proceed with a focused history and physical exam. Your patient might be asymptomatic, or could report non-specific symptoms like nose bleeds or headaches. Additionally, there might be a family history of hypertension. They may also have other ASCVD risk factors, including obesity, physical inactivity, tobacco use, hyperlipidemia, and diabetes. They may also have other comorbidities like coronary artery disease, heart failure, chronic kidney disease, and obstructive sleep apnea.

And don’t forget to assess for use of medications that can cause high blood pressure, such as contraceptives, corticosteroids, and NSAIDs!

Finally, let’s take a look at the physical exam. Be sure to check the blood pressure in both arms and listen for murmurs, gallops, and bruits to screen for cardiovascular abnormalities!

If the blood pressure is greater than 120 over 80 mmHg, you should suspect either elevated blood pressure or hypertension.

Ok, now that you suspect this, order screening labs, which include a TSH, CBC, CMP, lipid panel, and urinalysis, as well as an ECG. These will help identify other cardiovascular risk factors, assess for target-organ damage, and rule out secondary causes of hypertension, such as hyperthyroidism, polycythemia vera, hypercalcemia, and renal disease.

If it’s not secondary, TSH will typically be normal, while the remaining labs might reveal abnormalities due to comorbidities. For example, CBC may show anemia due to chronic kidney disease; while CMP might reveal an elevated creatinine, indicating kidney injury, or elevated glucose, indicating diabetes. Additionally, lipid panel may show elevated low-density lipoprotein, elevated triglycerides, as well as decreased high-density lipoprotein, which indicates hyperlipidemia; while urinalysis might show proteinuria, suggestive of kidney injury.

Finally, the ECG can help you evaluate cardiac, like left ventricular hypertrophy or ischemic heart disease.

After considering secondary causes and end-organ damage, your next step is to classify the patient’s blood pressure.”

If systolic blood pressure is between 120 and 129 and diastolic blood pressure is less than 80, diagnose Elevated Blood Pressure.

Sources

  1. "ASCVD Risk Estimator Plus application" American College of Cardiology (2023)
  2. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines" Hypertension (2018)
  3. "I have a patient with hypertension. How do I determine the cause?" Symptom to Diagnosis an Evidence Based Guide, 4th ed. (2020)
  4. "Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: filling a guidance gap: a scientific statement from the American Heart Association" Hypertension (2021)
  5. "Molecular Interactions of Arterial Hypertension in Its Target Organs" Int J Mol Sci (2021)
  6. "Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline" Circulation (2018)
  7. "Hypertension" CDIM CORE MEDICINE CLERKSHIP CURRICULUM GUIDE, 4th ed. (2020)